In our experimental setup STK33 interacted with hypoxia-stabilized HIF-1α in HCT-116 colon, MIA PaCa2 (Figure 4A) and MDA-MB-231 breast cancer cells (Supplementary Figure 2C) suggesting a potential role of STK33 in hypoxic tumors. Here, STK33 is linked to breast carcinoma.